Rare diseases
Investigational molecules
Locations
Back to Germany1 clinical trial in Bitburg, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on Acute Coronary Syndrome and post-heart attack care. These trials are evaluating new therapeutic approaches for preventing recurring cardiovascular events in patients who have experienced a heart attack.
The studies are examining the effectiveness of milvexian alongside standard treatments in reducing major adverse cardiovascular events, including cardiovascular death, myocardial infarction, and ischemic stroke.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
